{"DataElement":{"publicId":"3158920","version":"1","preferredName":"Concomitant Agent Indication Text","preferredDefinition":"Reason for the administration of a concomitant agent or measure.","longName":"CM_IND_TXT","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2012886","version":"3","preferredName":"Concomitant Agent Indication","preferredDefinition":"Reason for the administration of a concomitant agent or measure.","longName":"CONCT_AGT_MSR_INDCN","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"2206526","version":"1","preferredName":"Concomitant Agent","preferredDefinition":"Concomitant; following as a consequence.:An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C25730:C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant","conceptCode":"C25730","definition":"Accessory, accompanying especially in a subordinate or incidental way, occurring or existing during the same period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F886-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2192146","version":"1","preferredName":"INDICATIONS","preferredDefinition":"No value exists.","longName":"INDICATIONS","context":"CCR","contextVersion":"1","Concepts":[{"longName":"INDICATIONS","conceptCode":"C0237000","definition":"No value exists.","evsSource":"UMLS_CUI","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E75F33C5-A1F2-7433-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2004-11-14","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A689FA2E-6CDA-57C4-E034-0003BA0B1A09","latestVersionIndicator":"Yes","beginDate":"2002-07-24","endDate":null,"createdBy":"JASUR","dateCreated":"2002-07-24","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3158919","version":"1","preferredName":"Concomitant Agent Indication Text","preferredDefinition":"Concomitant medication indication text description","longName":"CM_IND_TXT","context":"NCIP","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3158918","version":"1","preferredName":"Concomitant Agent Indication Text","preferredDefinition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.:A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).:Text; the words of something written.","longName":"C70902:C41184:C25704","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Concomitant Agent","conceptCode":"C70902","definition":"A pharmaceutical agent other than agent(s) tested in a given protocol that is administered to or used by a subject either prior to or during the study. Supportive care and essential ancillary medications required by a treatment regimen should be clearly identified. A protocol's complete instructions including appropriate indication, dosage, administration route, schedule, restrictions to use, and any other relevant data should be explicitly stated. Concept also refers to substance(s) used prior or during the study that are not specified by the protocol.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Indication","conceptCode":"C41184","definition":"A sign, signal, circumstance, or symptom which serves to indicate or point out the cause, pathology, treatment, or issue of an attack of disease; the basis for initiation of a treatment for a disease or of a diagnostic test (causal, or symptomatic, or disease-specific indication).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Text","conceptCode":"C25704","definition":"The words of something written.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"951F2A55-4615-649A-E040-BB89AD433BD1","latestVersionIndicator":"Yes","beginDate":"2010-11-15","endDate":null,"createdBy":"LUY","dateCreated":"2010-11-15","modifiedBy":"ONEDATA","dateModified":"2010-11-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"951F2A55-4626-649A-E040-BB89AD433BD1","latestVersionIndicator":"Yes","beginDate":"2010-11-15","endDate":null,"createdBy":"LUY","dateCreated":"2010-11-15","modifiedBy":"TSESU","dateModified":"2018-05-29","changeDescription":"5/29/18 - smt CDE transferred to NCIP ownership per NINDS (Muniza Sheikh) request.\r\n","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6272292","version":"1","longName":"NINDS","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3151264","version":"1","longName":"Treatment/Intervention Data","context":"NCIP"},{"publicId":"10000418","version":"1","longName":"Drugs","context":"NCIP"},{"publicId":"3151266","version":"1","longName":"Prior and Concomitant Medications","context":"NCIP"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"Prior and Concomitant Medicat","type":"Preferred Question Text","description":"Prior and Concomitant Medication Indication","url":null,"context":"NCIP"},{"name":"NINDS CDE Project","type":"REFERENCE","description":"NINDS CDE Project","url":"http://www.commondataelements.ninds.nih.gov/","context":"NCIP"}],"origin":"NINDS:National Institute of Neurological Disorders and Stroke Common Data Element Project","workflowStatus":"RELEASED","registrationStatus":"Application","id":"951F61F9-91CE-E572-E040-BB89AD432F6A","latestVersionIndicator":"Yes","beginDate":"2010-11-15","endDate":null,"createdBy":"LUY","dateCreated":"2010-11-15","modifiedBy":"HARTLEYG","dateModified":"2018-12-11","changeDescription":"5/25/18 - smt CDE transferred to NCIP ownership per NINDS (Muniza Sheikh) request.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}